Respiratory clinical trials are costly and inefficient,
Our mission is to accelerate therapies to patients.
$985M average R&D costs for novel therapeutics58% of respiratory drugs fail at the final phase of trials1 of every 7 adults suffers from a lung disorderLung is the #1 most expensive clinical trial disease category
Lung Intelligence enables data-driven clinical trials, empowering efficiencies through precision endpoints, optimized imaging operations, and data insights.
